30:00 Keynote Lecture 1: The impact of the revolution in hepatitis C treatment on hepatocellular cancer HMP Education
18:26 When to choose for neo-adjuvant instead of adjuvant treatment in pancreatic cancer? HMP Education
21:22 Understanding the molecular heterogeneity of CRC cancer and its clinical implications HMP Education
32:04 Keynote Lecture 4: Market access or patient access? The licensing vs. reimbursement decision process HMP Education
27:18 Keynote Lecture 5: The value of whole body diffusion-weighted MRI for staging patients with CRC HMP Education
15:55 How did the multimodality trials change practice in the management of patients with mCRC? HMP Education
16:53 Are gene signatures ready for use in the selection of patients for adjuvant treatment? HMP Education
